Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02718417
What this trial is testing

Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

Who this might be right for
Ovarian Cancer
Pfizer 998
Not applicableLooking for participantsNCT07282158
What this trial is testing

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

Who this might be right for
Ovarian CarcinomaPsychiatric Disorder
Fred Hutchinson Cancer Center 25
Not applicableStudy completedNCT02406235
What this trial is testing

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Who this might be right for
Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer
AstraZeneca 710
Testing effectiveness (Phase 2)Study completedNCT01644825
What this trial is testing

Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 72
Not applicableLooking for participantsNCT07557225
What this trial is testing

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Urothelial Carcinoma (UC)Colorectal Cancer+11 more
Peking University First Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00277290
What this trial is testing

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Who this might be right for
Ovarian Cancer
Symphony Evolution, Inc. 24
Not applicableUnknownNCT00155896
What this trial is testing

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Taiwan University Hospital 100
Large-scale testing (Phase 3)Active Not RecruitingNCT03602859
What this trial is testing

A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsOvarian, Fallopian Tube and Primary Peritoneal Carcinoma
Tesaro, Inc. 1,400
Testing effectiveness (Phase 2)Ended earlyNCT01200797
What this trial is testing

SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT04354246
What this trial is testing

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Who this might be right for
Advanced CancerOvarian CancerLung Cancer+6 more
Compugen Ltd 94
Early research (Phase 1)Study completedNCT00315861
What this trial is testing

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+1 more
SCRI Development Innovations, LLC 15
Not applicableLooking for participantsNCT06728670
What this trial is testing

Pharmacokinetic Study of Tranexamic Acid

Who this might be right for
Ovarian Neoplasm Epithelial
Zhejiang Cancer Hospital 30
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Looking for participantsNCT06303505
What this trial is testing

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Who this might be right for
Ovarian CancerNon-small Cell Lung Cancer
Tubulis GmbH 250
Early research (Phase 1)UnknownNCT04768868
What this trial is testing

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Impact Therapeutics, Inc. 350
Not applicableStudy completedNCT04525183
What this trial is testing

REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue

Who this might be right for
Ovarian CancerFatigueCoping Behavior+1 more
Dana-Farber Cancer Institute 49
Very early researchUnknownNCT04503980
What this trial is testing

ΑPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Who this might be right for
Colorectal CancerOvarian Cancer
Shanghai Cell Therapy Group Co.,Ltd 10
Not applicableStudy completedNCT02317120
What this trial is testing

BRCA1 and BRCA2 Mutation in Romanian Population: a Study of Genotype - Phenotype Correlation at Diagnosis With Prospective Disease Outcome and Survival

Who this might be right for
To Determine the Prevalence, Penetrance of BRCA1 and BRCA2 Mutations in Romanian Womens With Breast or Ovarian Cancer
Alexandru Eniu 250
Testing effectiveness (Phase 2)Study completedNCT05494580
What this trial is testing

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian CarcinomaPlatinum-resistant Ovarian Cancer+2 more
Sun Yat-sen University 29
Testing effectiveness (Phase 2)Study completedNCT00318370
What this trial is testing

Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Morphotek 58
Next Page